We are live on ! Find out more
OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

Back to rankings

92 hedge funds and large institutions have $186M invested in Osiris Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 18

6% more funds holding

Funds holding: 87 → 92 (+5)

1% more capital invested

Capital invested by funds: $184M → $186M (+$2.6M)

4% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 27

89% less call options, than puts

Call options by funds: $385K | Put options by funds: $3.53M

Holders
92
Holders Change
+5
Holders Change %
+5.75%
% of All Funds
2.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
26
Reduced
27
Closed
18
Calls
$385K
Puts
$3.53M
Net Calls
-$3.15M
Net Calls Change
+$2.95M

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$16.6M
2
HRCM
Hood River Capital Management
Florida
+$3.95M
3
RFC
Russell Frank Company
Washington
+$1.48M
4
GPP
Great Point Partners
Connecticut
+$1.45M
5
TC
TFS Capital
Pennsylvania
+$1.45M

Top Sellers

Rank Fund Capital Flow
1
VCM
Venator Capital Management
Ontario, Canada
-$4.25M
2
OAM
Oxford Asset Management
United Kingdom
-$2.5M
3
TI
Turner Investments
Pennsylvania
-$1.78M
4
BIT
BlackRock Institutional Trust
California
-$1.7M
5
Morgan Stanley
Morgan Stanley
New York
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
26
Spark Investment Management
New York
$1.11M +$631K +32,700 +118%
TCIM
27
TIAA CREF Investment Management
New York
$1.09M – – –
EI
28
EAM Investors
California
$1.05M +$1.09M +56,694 New
Goldman Sachs
29
Goldman Sachs
New York
$924K +$966K +50,033 New
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$804K -$1M -51,905 -54%
AllianceBernstein
31
AllianceBernstein
Tennessee
$726K -$27K -1,400 -3%
AI
32
Axiom Investors
Connecticut
$714K -$594K -30,770 -44%
Fisher Asset Management
33
Fisher Asset Management
Washington
$651K +$681K +35,270 New
SAMC
34
Shinko Asset Management Company
Japan
$651K +$681K +35,270 New
PCMI
35
Princeton Capital Management Inc
New Jersey
$643K – – –
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$641K -$1.93K -100 -0.3%
DC
37
Deere & Company
Illinois
$574K – – –
KG
38
Killen Group
Pennsylvania
$554K -$88.8K -4,600 -13%
ProShare Advisors
39
ProShare Advisors
Maryland
$519K -$34.7K -1,799 -6%
TA
40
Teachers Advisors
New York
$510K – – –
FPC
41
Falcon Point Capital
California
$491K -$753 -39 -0.1%
CS
42
Credit Suisse
Switzerland
$483K -$384K -19,901 -43%
Swiss National Bank
43
Swiss National Bank
Switzerland
$475K +$71.4K +3,700 +17%
State Board of Administration of Florida Retirement System
44
State Board of Administration of Florida Retirement System
Florida
$435K – – –
PSC
45
Piper Sandler & Co
Minnesota
$406K +$425K +22,000 New
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$393K – – –
HK
47
Horizon Kinetics
New York
$388K +$38.6K +2,000 +11%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$364K +$12.3K +635 +3%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$349K -$23.3K -1,205 -6%
CAM
50
ClariVest Asset Management
California
$323K +$1.93K +100 +0.6%
1
2
3 4 5

OSIR Hedge Fund Activity: Q3 2015 in Review

92 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q3 2015, worth a combined $186M — up 1.4% from $184M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new OSIR positions and 18 closed out — a net gain of 5 holders — while 26 added to existing stakes and 27 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $16.6M. The largest seller was Venator Capital Management, exiting entirely with an estimated $4.25M sold.

  • 92 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q3 2015, up from 87 in Q2 2015.
  • Funds reported $186M of Osiris Therapeutics, Inc. Common Stock stock for Q3 2015, up 1.4% quarter-over-quarter.
  • 23 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q3 2015 and 18 closed out, a net change of +5 holders.
  • The largest Osiris Therapeutics, Inc. Common Stock buyer in Q3 2015 was Consonance Capital Management, an estimated $16.6M added.
  • The largest Osiris Therapeutics, Inc. Common Stock seller in Q3 2015 was Venator Capital Management, an estimated $4.25M sold.

Based on aggregated 13F filings for Q3 2015.